Trending
- Nigeria inflation cools in August, but analysts warn dip could be short-lived
- Africa’s race against time: Why climate adaptation can’t wait
- Fertilizer giant OCP Group and IFC sign $108M deal to tackle Morocco’s water crisis
- Why Ghana’s new-look $60M Jamestown Fishing Port is catalyst for jobs growth
- Unleash your creativity: UAE Engineering Award welcomes innovators
- China’s 6,000-troop training program in Africa: What’s the real agenda?
- How FOCAC 2024 paved the way for deeper China-Africa collaboration
- TAZARA reborn: China, Tanzania sign landmark railway revamp agreement
Browsing: Bavarian Nordic
- Africa CDC has announced an ambitious alliance with vaccine maker Bavarian Nordic to secure 10 million doses of the mpox vaccine by the end of 2025.
- Vaccine maker Bavarian Nordic says it can supply up to 2 million doses by the end of 2024.
- Mpox outbreak has been particularly severe, prompting Africa CDC to declare it a PHECS on August 13, 2024.
In response to the escalating threat of mpox across the Africa, the Africa Centers for Disease Control and Prevention (Africa CDC) has announced an ambitious plan to secure 10 million doses of the mpox vaccine by the end of 2025.
This commitment comes in collaboration with Bavarian Nordic, a leading vaccine manufacturer, which has pledged to ramp up production and ensure the equitable distribution of vaccines.
The initiative is a critical step in tackling the ongoing mpox outbreak, which has been declared a Public Health Emergency of …